Human testing is due to start in mid-July and, if successful, the companies could manufacture about 100-million doses by the end of 2021
The company was found to have contravened the Competition Act after it increased prices for three types of masks
Working with Pfizer, BioNTech says testing shows that the vaccine ‘yields immune activity and causes a strong immune response’
Price may reflect looming competition from cheap steroid
Results from a trial showed that dexamethasone reduced death rates by about a third
Aspen CEO Stephen Saad talks to Business Day TV about the company’s capacity to meet the growing demand for life-saving medication
The pharmaceutical manufacturer is a leading global supplier of dexamethasone, which trials show cuts the risk of death among some Covid-19 patients
The drug maker has rights to dexamethasone, with preliminary results of a trial in the UK showing it can be life-saving for some Covid-19 patients
The announcement comes days after the group said it had successfully negotiated an extension of its debt payments
Hospital group switches to manual processing systems which may lead to administrative delays
Lenders give the drug maker 18 months to tame a debt burden that is 10 times its market cap
It is the first time in the 35-year history of SA’s biggest private hospital group that it has taken step
Private hospital group warns pandemic effects could last another 12 months
The private hospital group takes steps to preserve cash as Covid-19 storm batters the sector
A plunge in hospital admissions weighed on income, the private hospital group says
Netcare blames part of the fall in earnings on changes in accounting standards
However, there has been concern that the US could have a vaccine before other countries thanks to its funding of big pharmaceutical firms
Dis-Chem CFO Rui Morais and Advanced Health CEO Gerhard van Emmenis talk to Business Day TV
The shares jump 30% after the biotech company reports promising results from first study
The Covid-19 pandemic has boosted demand for some of the drug maker’s products, although the pandemic’s effect in China has had a bad effect
